Stocks in play: Satellos Bioscience Inc.
Announced today its financial results and operational highlights for the year ended December 31, 2023. For the year ended December 31, 2023, Satellos reported a net loss of $15.9 million ($0.18 loss per share), compared to a net loss $11.3 million ($0.32 loss per share) for the year ended December 31, 2022. Satellos Bioscience Inc. shares T.MSCL are trading down $0.01 at $0.45.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.